StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set a "hold" rating on the stock.
Milestone Scientific Stock Down 0.4 %
MLSS traded down $0.00 during midday trading on Wednesday, reaching $0.90. 28,746 shares of the company's stock were exchanged, compared to its average volume of 133,659. The business has a 50-day simple moving average of $0.99 and a two-hundred day simple moving average of $0.96. The firm has a market capitalization of $70.18 million, a price-to-earnings ratio of -12.87 and a beta of 1.12. Milestone Scientific has a one year low of $0.54 and a one year high of $1.39.
Institutional Trading of Milestone Scientific
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific during the third quarter worth $48,000. World Investment Advisors LLC bought a new stake in Milestone Scientific during the 3rd quarter worth about $91,000. Renaissance Technologies LLC lifted its position in Milestone Scientific by 72.8% during the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock valued at $121,000 after purchasing an additional 53,198 shares during the period. Carnegie Investment Counsel boosted its stake in shares of Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock valued at $166,000 after purchasing an additional 27,412 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in shares of Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock worth $480,000 after buying an additional 31,572 shares during the period. Institutional investors and hedge funds own 5.79% of the company's stock.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Stories
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
